Olema Pharmaceuticals, Inc.

OLMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 21, 2026 8-K
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
8-K May 1, 2026 8-K
4 Apr 29, 2026
3 Apr 29, 2026
ARS Apr 29, 2026 ARS
DEFA14A Apr 29, 2026 DEFA14A
DEF 14A Apr 29, 2026 DEF 14A
8-K Apr 29, 2026 8-K
SCHEDULE 13G Mar 20, 2026
144 Mar 16, 2026
144 Mar 16, 2026
S-8 Mar 16, 2026 S-8
10-K Mar 16, 2026 10-K
8-K Mar 16, 2026 8-K
144 Mar 11, 2026
144 Mar 10, 2026
144 Mar 9, 2026
SCHEDULE 13G/A Mar 6, 2026
4 Mar 5, 2026
144 Mar 4, 2026
144 Mar 4, 2026
← Newer Page 2 of 23 · 562 filings Older →